Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 6061 AL 6075

Testing the right target and right drug at the right stage

Sperling RA, Jack CR Jr, Aisen PS.

Sci Transl Med. 2011 Nov 30;3(111):111cm33. doi: 10.1126/scitranslmed.3002609.

Antioxidant properties of natural polyphenols and their therapeutic potentials for Alzheimer's disease

Choi DY, Lee YJ, Hong JT, Lee HJ.

Brain Res Bull. 2012 Feb 10;87(2-3):144-53. doi: 10.1016/j.brainresbull.2011.11.014. Epub 2011 Nov 28.

Characterization of oral disintegrating film containing donepezil for Alzheimer disease

Liew KB, Tan YT, Peh KK.

AAPS PharmSciTech. 2012 Mar;13(1):134-42. doi: 10.1208/s12249-011-9729-4. Epub 2011 Dec 14.

Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's disease

Cuadrado-Tejedor M, García-Osta A, Ricobaraza A, Oyarzabal J, Franco R.

Curr Med Chem. 2011;18(36):5545-53. doi: 10.2174/092986711798347315.

The beneficial role of vitamin D in Alzheimer's disease

Lu'o'ng KV, Nguyên LT.

Am J Alzheimers Dis Other Demen. 2011 Nov;26(7):511-20. doi: 10.1177/1533317511429321. Epub 2011 Dec 27.

Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier

Banks WA.

Adv Drug Deliv Rev. 2012 May 15;64(7):629-39. doi: 10.1016/j.addr.2011.12.005. Epub 2011 Dec 17.

Management of moderate to severe Alzheimer's disease: focus on memantine

Dominguez E, Chin TY, Chen CP, Wu TY.

Taiwan J Obstet Gynecol. 2011 Dec;50(4):415-23. doi: 10.1016/j.tjog.2011.10.004.

Vitamin A and Alzheimer's disease

Ono K, Yamada M.

Geriatr Gerontol Int. 2012 Apr;12(2):180-8. doi: 10.1111/j.1447-0594.2011.00786.x. Epub 2011 Dec 23.

Sertraline for the treatment of depression in Alzheimer disease: genetic influences

Peters ME, Vaidya V, Drye LT, Rosenberg PB, Martin BK, Porsteinsson AP, Frangakis CE, Mintzer J, Weintraub D, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG, Avramopoulos D; DIADS-2 Research Group.

J Geriatr Psychiatry Neurol. 2011 Dec;24(4):222-8. doi: 10.1177/0891988711422527.

Effective pharmacological management of Alzheimer's disease

Atri A.

Am J Manag Care. 2011 Nov;17 Suppl 13:S346-55.

A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease

Anand P, Singh B, Singh N.

Bioorg Med Chem. 2012 Feb 1;20(3):1175-80. doi: 10.1016/j.bmc.2011.12.042. Epub 2011 Dec 30.

[The minimum efficiency of drugs against Alzheimer's disease]

Deleuze J.

Rev Prat. 2011 Nov;61(9):1187.

[Effects of donepezil treatment on platelets α and β secretase activities in Alzheimer's disease patients]

Dong GS, Li X, Jiang QH, Yang HQ.

Zhonghua Yi Xue Za Zhi. 2011 Dec 20;91(47):3341-5.

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease

D'Onofrio G, Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Paroni G, Cascavilla L, Seripa D, Pilotto A.

Expert Opin Drug Discov. 2012 Jan;7(1):19-37. doi: 10.1517/17460441.2012.645534. Epub 2011 Dec 14.

GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease

Gao C, Hölscher C, Liu Y, Li L.

Rev Neurosci. 2011 Dec 21;23(1):1-11. doi: 10.1515/rns.2011.061.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias